NewEdge Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.59M | Sell |
109,954
-322,391
| -75% | -$22.3M | 0.04% | 439 |
|
|
2025
Q1 | $30M | Buy |
432,345
+97,377
| +29% | +$6.76M | 0.18% | 115 |
|
|
2024
Q4 | $28.8M | Buy |
334,968
+12,813
| +4% | +$1.1M | 0.17% | 122 |
|
|
2024
Q3 | $38.4M | Buy |
322,155
+3,575
| +1% | +$426K | 0.25% | 90 |
|
|
2024
Q2 | $45.5M | Buy |
318,580
+228,889
| +255% | +$32.7M | 0.33% | 57 |
|
|
2024
Q1 | $11.5M | Buy |
89,691
+17,390
| +24% | +$2.23M | 0.1% | 204 |
|
|
2023
Q4 | $7.53M | Buy |
72,301
+21,003
| +41% | +$2.19M | 0.07% | 265 |
|
|
2023
Q3 | $4.66M | Buy |
51,298
+8,092
| +19% | +$736K | 0.05% | 335 |
|
|
2023
Q2 | $3.5M | Buy |
43,206
+19,100
| +79% | +$1.55M | 0.04% | 409 |
|
|
2023
Q1 | $1.93M | Sell |
24,106
-3,264
| -12% | -$261K | 0.02% | 553 |
|
|
2022
Q4 | $1.17M | Buy |
27,370
+3,204
| +13% | +$137K | 0.03% | 470 |
|
|
2022
Q3 | $1.2M | Sell |
24,166
-1,558
| -6% | -$77.6K | 0.02% | 576 |
|
|
2022
Q2 | $1.43M | Sell |
25,724
-19,320
| -43% | -$1.08M | 0.02% | 530 |
|
|
2022
Q1 | $2.5M | Sell |
45,044
-1,350
| -3% | -$75K | 0.04% | 371 |
|
|
2021
Q4 | $2.6M | Buy |
46,394
+20,154
| +77% | +$1.13M | 0.04% | 377 |
|
|
2021
Q3 | $1.26M | Sell |
26,240
-2,364
| -8% | -$114K | 0.03% | 445 |
|
|
2021
Q2 | $1.2M | Buy |
28,604
+2,802
| +11% | +$117K | 0.03% | 441 |
|
|
2021
Q1 | $870K | Buy |
25,802
+19,292
| +296% | +$650K | 0.03% | 495 |
|
|
2020
Q4 | $227K | Hold |
6,510
| – | – | 0.01% | 854 |
|
|
2020
Q3 | $226K | Sell |
6,510
-216
| -3% | -$7.5K | 0.01% | 789 |
|
|
2020
Q2 | $220K | Buy |
+6,726
| New | +$220K | 0.01% | 753 |
|
|
2017
Q3 | – | Sell |
-162
| Closed | -$3.41K | – | 863 |
|
|
2017
Q2 | $3.41K | Buy |
+162
| New | +$3.41K | ﹤0.01% | 1221 |
|